NCT03326921
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +63 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive
Explore clinical trials studying Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study